Skip to main content
. Author manuscript; available in PMC: 2019 Apr 24.
Published in final edited form as: Pediatrics. 2019 Jan;143(Suppl 1):S6–S13. doi: 10.1542/peds.2018-1099C

TABLE 3.

Parents’ and Clinicians’ Attitudes

Parents’ Attitudes Clinicians’ Attitudes

N Disagree, % Neither Agree nor Disagree, % Agree, % N Disagree, % Neither Agree nor Disagree, % Agree, %
Every newborn should receive
 NBS 494 1 6 93 146 100
 GS 494 10 57 33 146 42 50 8
Parental informed consent should be required for
 NBS 493 22 21 57 147 54 15 31
 GS 492 3 11 86 147 1 5 93
There are health benefits associated with
 NBS 493 2 16 82 145 1 2 97
 GS 494 2 27 71 147 5 44 51
There are risks associated with
 NBS 490 50 31 19 144 48 13 39
 GS 493 28 37 35 148 4 26 70
Concerned about the privacy of child’s genomic Informationa,b 493 17 18 65 145 4 13 83
Concerned child will be discriminated against on the basis of genomic informationc,d 490 22 25 53 147 8 20 72

Response options were on a scale ranging from strongly disagree (1) to strongly agree (5). Scores 1 and 2 were combined to create the disagree category. Scores 4 and 5 were combined to create the agree category. —, not applicable.

a

Parent survey question: I am concerned about the privacy of my child’s genomic information.

b

Clinician survey question: My patients’ parents should be concerned about the privacy of their child’s genomic information.

c

Parent survey question: I am concerned that my child will be discriminated against on the basis of his or her genomic information.

d

Clinician survey question: My patients’ parents should be concerned that their child will be discriminated against on the basis of his or her genomic information.